Moreover, deletion of PTEN in mouse models of sarcomas and prostate cancer demonstrated that it plays a role in tumor progression causing the infiltration of myeloid-derived hematopoietic cells [283–285]. The gene discussed is PTEN; the disease is neoplasm.